Every recall we track for CIPLA — 11 in all — plus the complaints and injury reports the public filed about them.
Cipla recalls certain batches of Arformoterol Tartrate Inhalation Solution due to environmental monitoring failure causing lack of sterility. This could lead to infections if used.
Cipla recalls 0.25mg/2mL Budesonide inhalation suspension due to lack of sterility assurance. Affected lots expire 01/2024. Stop using immediately if you have this prescription medication.
Cipla recalls 0.05% Difluprednate Ophthalmic Emulsion bottles due to potential sterility issues from protective cap breakage. Affected lots expire 01/2023 to 07/2023.
CIPLA recalls 0.05% Difluprednate Ophthalmic Emulsion bottles due to potential contamination from broken protective caps. This medication is prescription-only and may cause eye infections if not sterile.
CIPLA recalls 10mg solifenacin tablets due to manufacturing deviations. Affected lots from June 2021. Consumers should contact for details.
